eHealth (EHTH)
(Delayed Data from NSDQ)
$4.40 USD
+0.36 (8.91%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $4.42 +0.02 (0.45%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$4.40 USD
+0.36 (8.91%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $4.42 +0.02 (0.45%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Zacks News
eHealth's Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in eHealth.
Is eHealth (EHTH) Outperforming Other Finance Stocks This Year?
by Zacks Equity Research
Is (EHTH) Outperforming Other Finance Stocks This Year?
EHealth (EHTH) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
eHealth (EHTH) delivered earnings and revenue surprises of 124.39% and 72.53%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
eHealth (EHTH) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
eHealth's (EHTH) Q2 results are likely to benefit from solid performance of its Medicare business.
Earnings Preview: eHealth (EHTH) Q2 Earnings Expected to Decline
by Zacks Equity Research
EHealth (EHTH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Insurance - Brokerage Industry Near-Term Outlook Bright
by Tanuka De
Insurance - Brokerage Industry is poised for growth given growing demand for insurance amid a dynamic and complex business environment.
Aon (AON) Stock Up 37.9% in a Year: Will the Rally Continue?
by Zacks Equity Research
Aon's (AON) inorganic growth profile should favor revenue growth. This will likely perk up its share price further.
Marsh & McLennan's Unit Ties Up With Corridor Platforms
by Zacks Equity Research
Marsh & McLennan's (MMC) arm Oliver Wyman teams up with Corridor Platforms to launch a new platform for providing solutions to banks and non-bank financial institutions.
Aon to Offer Micro Insurance in Sri Lanka Via Blockchain
by Zacks Equity Research
Aon (AON) collaborates with Oxfam and Etherisc to provide Sri Lankan farmers with accessibility to a blockchain platform.
eHealth Surges 114% Year to Date: Will the Rally Continue?
by Zacks Equity Research
eHealth's (EHTH) operational excellence and growth initiatives help the stock continue the bull run.
ECB Hints at Rate Cut, Will Fed Follow Suit? Likely Gainers
by Nalak Das
Market participants will be more interested in Powell's speech scheduled Wednesday afternoon. His statement is likely to reveal much about the central bank's future policy stance.
Arthur J. Gallagher Expands in Australia With P2 Group Buyout
by Zacks Equity Research
Arthur J. Gallagher's (AJG) recent buyout of Australian company P2 Group bears testimony to its efforts to expand internationally.
Arthur J. Gallagher Buys California-Based Abram Interstate
by Zacks Equity Research
Arthur J. Gallagher (AJG) acquires Abram Interstate Insurance to consolidate its presence in California and capitalize on growth opportunities in the state.
Here's Why Momentum Investors Will Love eHealth (EHTH)
by Zacks Equity Research
Does eHealth (EHTH) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks.com featured highlights include: Qiwi, HEICO, Hallmark, eHealth and Goosehead
by Zacks Equity Research
Zacks.com featured highlights include: Qiwi, HEICO, Hallmark, eHealth and Goosehead
5 Stocks With Recent Price Strength Amid Market Volatility
by Nalak Das
No matter how disciplined and systematic investors are, equity market volatility will always manage to get the better of them.
The Zacks Analyst Blog Highlights: OptimizeRx, eHealth, Strategic Education, Hibbett Sports and PC-Tel
by Zacks Equity Research
The Zacks Analyst Blog Highlights: OptimizeRx, eHealth, Strategic Education, Hibbett Sports and PC-Tel
Willis Towers Set to Grow on Rising Commissions and Fees
by Zacks Equity Research
Willis Towers (WLTW) remains well poised on organic growth in commissions and fees, solid customer retention, growing new business and improving liquidity, though high costs concern.
5 Stocks Likely to Fly High on Powell's Rate Cut Hint
by Nalak Das
Powell's statement is in sharp contrast to his aggressive monetary stance in 2018 and a steady monetary policy for 2019, which he reaffirmed last month.
Why Should You Hold Aon (AON) in Your Portfolio Right Now?
by Zacks Equity Research
Riding high on the rising top line and growth strategies, Aon (AON) holds immense potential to reap benefits for investors.
Arthur J. Gallagher Announces Buyout of Protectors Group
by Zacks Equity Research
Arthur J. Gallagher (AJG) has acquired The Protectors Insurance to consolidate its presence in Western Sydney and capitalize on the growth opportunities there.
Aon Ties Up With CoverWallet to Establish Presence in Australia
by Zacks Equity Research
With this tie-up, Aon (AON) gets an access to the evolving small and medium enterprise (SME) digital insurance market segment worth $100 billion.
Arthur J. Gallagher Announces Cairnstone Financial Buyout
by Zacks Equity Research
Arthur J. Gallagher's (AJG) buyout of Cairnstone Financial will boost the acquirer's product offerings.
Why Should You Hold Marsh & McLennan in Your Portfolio?
by Zacks Equity Research
Riding high on a steady top line, sturdy financial position and inorganic growth, Marsh & McLennan (MMC) has high potential to reap benefits for investors.
3 Reasons Why eHealth (EHTH) Is a Great Growth Stock
by Zacks Equity Research
eHealth (EHTH) possesses solid growth attributes, which could help it handily outperform the market.